Loading…

Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes

Human Epstein-Barr virus (EBV) specific cytotoxic T lymphocytes (CTL) play an important role in maintaining the virus/host equilibrium during persistent infections. We analysed precursors of anti-EBV CTL by the limiting-dilution technique. Seven healthy EBV-seropositive and two EBV-seronegative dono...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental immunology 1991-06, Vol.84 (3), p.501-507
Main Authors: BOURGAULT, I, GOMEZ, A, GOMARD, E, LEVY, J. P
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 507
container_issue 3
container_start_page 501
container_title Clinical and experimental immunology
container_volume 84
creator BOURGAULT, I
GOMEZ, A
GOMARD, E
LEVY, J. P
description Human Epstein-Barr virus (EBV) specific cytotoxic T lymphocytes (CTL) play an important role in maintaining the virus/host equilibrium during persistent infections. We analysed precursors of anti-EBV CTL by the limiting-dilution technique. Seven healthy EBV-seropositive and two EBV-seronegative donors were tested. All the donors seropositive for EBV gave clear-cut positive results, and it was remarkable that the frequency of CTL precursors (CTLp) observed was much higher than that reported for other viruses. In contrast, in the seronegative donors the frequency of CTLp was undetectable. The CTLp were derived from the CD4-CD8+ population only, although EBV-specific CD4+ cytolytic T cell clones have been described. A study of the HLA restriction showed that some HLA-A or HLA-B antigens can function as preferential restricting molecules, but that CTLp restricted by the other HLA-A or HLA-B molecules also exist. However, the dominant population of CTL present in primary responses is sometimes different from that of long term cell lines established from the same donor.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1535418</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80599259</sourcerecordid><originalsourceid>FETCH-LOGICAL-p206t-50e32347f134fc29e869d2e29c9f8a3bd55a89fe41aaf40b5b1be9f2a67b31473</originalsourceid><addsrcrecordid>eNpVkE9r20AQxUVpSdy0HyGgS3pb2P_WXgKJceKCoRf3LEbr3XjCaqXurgz69hWNadrTzLzf8B4zH6oVE1oRzqX5WK0opYYYRuV19Tnn12XUWvOr6oppqWmjV1W_xx4LxhdyxDAVHGINEcKcMdeDr8vJ1bv9Q51cLgntH77IEAuS7ZiLw0geIaX6jGnKJI_Ookdb27kMYS5Ld6jD3I-nYVFc_lJ98hCy-3qpN9XPp-1hsyP7H8_fNw97MnKqC1HUCS7k2jMhveXGNdocuePGGt-A6I5KQWO8kwzAS9qpjnXOeA563Qkm1-Kmun_zHaeud0frYkkQ2jFhD2luB8D2fxLx1L4M55YpoSRrFoNvF4M0_JqW49ses3UhQHTDlNuGKmO4Msvi7b9JfyMuD1743YVDthB8gmgxv6-ZhnGjG_Eb4CqIeA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80599259</pqid></control><display><type>article</type><title>Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes</title><source>PubMed (Medline)</source><creator>BOURGAULT, I ; GOMEZ, A ; GOMARD, E ; LEVY, J. P</creator><creatorcontrib>BOURGAULT, I ; GOMEZ, A ; GOMARD, E ; LEVY, J. P</creatorcontrib><description>Human Epstein-Barr virus (EBV) specific cytotoxic T lymphocytes (CTL) play an important role in maintaining the virus/host equilibrium during persistent infections. We analysed precursors of anti-EBV CTL by the limiting-dilution technique. Seven healthy EBV-seropositive and two EBV-seronegative donors were tested. All the donors seropositive for EBV gave clear-cut positive results, and it was remarkable that the frequency of CTL precursors (CTLp) observed was much higher than that reported for other viruses. In contrast, in the seronegative donors the frequency of CTLp was undetectable. The CTLp were derived from the CD4-CD8+ population only, although EBV-specific CD4+ cytolytic T cell clones have been described. A study of the HLA restriction showed that some HLA-A or HLA-B antigens can function as preferential restricting molecules, but that CTLp restricted by the other HLA-A or HLA-B molecules also exist. However, the dominant population of CTL present in primary responses is sometimes different from that of long term cell lines established from the same donor.</description><identifier>ISSN: 0009-9104</identifier><identifier>EISSN: 1365-2249</identifier><identifier>PMID: 1646086</identifier><identifier>CODEN: CEXIAL</identifier><language>eng</language><publisher>Oxford: Blackwell</publisher><subject>B-Lymphocytes - immunology ; Biological and medical sciences ; Hematopoietic Stem Cells - immunology ; Herpesvirus 4, Human - immunology ; HLA-A Antigens - immunology ; HLA-B Antigens - immunology ; Human viral diseases ; Humans ; Infectious diseases ; Medical sciences ; Miscellaneous ; T-Lymphocyte Subsets - immunology ; T-Lymphocytes, Cytotoxic - immunology ; Viral diseases</subject><ispartof>Clinical and experimental immunology, 1991-06, Vol.84 (3), p.501-507</ispartof><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1535418/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1535418/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19812968$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1646086$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BOURGAULT, I</creatorcontrib><creatorcontrib>GOMEZ, A</creatorcontrib><creatorcontrib>GOMARD, E</creatorcontrib><creatorcontrib>LEVY, J. P</creatorcontrib><title>Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes</title><title>Clinical and experimental immunology</title><addtitle>Clin Exp Immunol</addtitle><description>Human Epstein-Barr virus (EBV) specific cytotoxic T lymphocytes (CTL) play an important role in maintaining the virus/host equilibrium during persistent infections. We analysed precursors of anti-EBV CTL by the limiting-dilution technique. Seven healthy EBV-seropositive and two EBV-seronegative donors were tested. All the donors seropositive for EBV gave clear-cut positive results, and it was remarkable that the frequency of CTL precursors (CTLp) observed was much higher than that reported for other viruses. In contrast, in the seronegative donors the frequency of CTLp was undetectable. The CTLp were derived from the CD4-CD8+ population only, although EBV-specific CD4+ cytolytic T cell clones have been described. A study of the HLA restriction showed that some HLA-A or HLA-B antigens can function as preferential restricting molecules, but that CTLp restricted by the other HLA-A or HLA-B molecules also exist. However, the dominant population of CTL present in primary responses is sometimes different from that of long term cell lines established from the same donor.</description><subject>B-Lymphocytes - immunology</subject><subject>Biological and medical sciences</subject><subject>Hematopoietic Stem Cells - immunology</subject><subject>Herpesvirus 4, Human - immunology</subject><subject>HLA-A Antigens - immunology</subject><subject>HLA-B Antigens - immunology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>T-Lymphocyte Subsets - immunology</subject><subject>T-Lymphocytes, Cytotoxic - immunology</subject><subject>Viral diseases</subject><issn>0009-9104</issn><issn>1365-2249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNpVkE9r20AQxUVpSdy0HyGgS3pb2P_WXgKJceKCoRf3LEbr3XjCaqXurgz69hWNadrTzLzf8B4zH6oVE1oRzqX5WK0opYYYRuV19Tnn12XUWvOr6oppqWmjV1W_xx4LxhdyxDAVHGINEcKcMdeDr8vJ1bv9Q51cLgntH77IEAuS7ZiLw0geIaX6jGnKJI_Ookdb27kMYS5Ld6jD3I-nYVFc_lJ98hCy-3qpN9XPp-1hsyP7H8_fNw97MnKqC1HUCS7k2jMhveXGNdocuePGGt-A6I5KQWO8kwzAS9qpjnXOeA563Qkm1-Kmun_zHaeud0frYkkQ2jFhD2luB8D2fxLx1L4M55YpoSRrFoNvF4M0_JqW49ses3UhQHTDlNuGKmO4Msvi7b9JfyMuD1743YVDthB8gmgxv6-ZhnGjG_Eb4CqIeA</recordid><startdate>19910601</startdate><enddate>19910601</enddate><creator>BOURGAULT, I</creator><creator>GOMEZ, A</creator><creator>GOMARD, E</creator><creator>LEVY, J. P</creator><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19910601</creationdate><title>Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes</title><author>BOURGAULT, I ; GOMEZ, A ; GOMARD, E ; LEVY, J. P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p206t-50e32347f134fc29e869d2e29c9f8a3bd55a89fe41aaf40b5b1be9f2a67b31473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>B-Lymphocytes - immunology</topic><topic>Biological and medical sciences</topic><topic>Hematopoietic Stem Cells - immunology</topic><topic>Herpesvirus 4, Human - immunology</topic><topic>HLA-A Antigens - immunology</topic><topic>HLA-B Antigens - immunology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>T-Lymphocyte Subsets - immunology</topic><topic>T-Lymphocytes, Cytotoxic - immunology</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BOURGAULT, I</creatorcontrib><creatorcontrib>GOMEZ, A</creatorcontrib><creatorcontrib>GOMARD, E</creatorcontrib><creatorcontrib>LEVY, J. P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and experimental immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BOURGAULT, I</au><au>GOMEZ, A</au><au>GOMARD, E</au><au>LEVY, J. P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes</atitle><jtitle>Clinical and experimental immunology</jtitle><addtitle>Clin Exp Immunol</addtitle><date>1991-06-01</date><risdate>1991</risdate><volume>84</volume><issue>3</issue><spage>501</spage><epage>507</epage><pages>501-507</pages><issn>0009-9104</issn><eissn>1365-2249</eissn><coden>CEXIAL</coden><abstract>Human Epstein-Barr virus (EBV) specific cytotoxic T lymphocytes (CTL) play an important role in maintaining the virus/host equilibrium during persistent infections. We analysed precursors of anti-EBV CTL by the limiting-dilution technique. Seven healthy EBV-seropositive and two EBV-seronegative donors were tested. All the donors seropositive for EBV gave clear-cut positive results, and it was remarkable that the frequency of CTL precursors (CTLp) observed was much higher than that reported for other viruses. In contrast, in the seronegative donors the frequency of CTLp was undetectable. The CTLp were derived from the CD4-CD8+ population only, although EBV-specific CD4+ cytolytic T cell clones have been described. A study of the HLA restriction showed that some HLA-A or HLA-B antigens can function as preferential restricting molecules, but that CTLp restricted by the other HLA-A or HLA-B molecules also exist. However, the dominant population of CTL present in primary responses is sometimes different from that of long term cell lines established from the same donor.</abstract><cop>Oxford</cop><pub>Blackwell</pub><pmid>1646086</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-9104
ispartof Clinical and experimental immunology, 1991-06, Vol.84 (3), p.501-507
issn 0009-9104
1365-2249
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1535418
source PubMed (Medline)
subjects B-Lymphocytes - immunology
Biological and medical sciences
Hematopoietic Stem Cells - immunology
Herpesvirus 4, Human - immunology
HLA-A Antigens - immunology
HLA-B Antigens - immunology
Human viral diseases
Humans
Infectious diseases
Medical sciences
Miscellaneous
T-Lymphocyte Subsets - immunology
T-Lymphocytes, Cytotoxic - immunology
Viral diseases
title Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A45%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Limiting-dilution%20analysis%20of%20the%20HLA%20restriction%20of%20anti-Epstein-Barr%20virus-specific%20cytolytic%20T%20lymphocytes&rft.jtitle=Clinical%20and%20experimental%20immunology&rft.au=BOURGAULT,%20I&rft.date=1991-06-01&rft.volume=84&rft.issue=3&rft.spage=501&rft.epage=507&rft.pages=501-507&rft.issn=0009-9104&rft.eissn=1365-2249&rft.coden=CEXIAL&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E80599259%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p206t-50e32347f134fc29e869d2e29c9f8a3bd55a89fe41aaf40b5b1be9f2a67b31473%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=80599259&rft_id=info:pmid/1646086&rfr_iscdi=true